McKinsey Settles Opioid Case with $78M Payout to Insurers and Benefit Plans
TL;DR
McKinsey & Co. has agreed to a $78 million settlement with U.S. health insurers and benefit plans over allegations that its consulting work for drug companies, including Purdue Pharma, contributed to the opioid crisis. The settlement will establish a fund to reimburse third-party payers for opioid-related costs. McKinsey has reached several settlements related to the opioid epidemic, totaling over $900 million, but maintains that its past work was lawful. The settlement is pending judicial approval.
Topics:businessbusiness-and-legal##business-and-legal#healthinsurers#legalsettlement#mckinseysettlement#opioidcrisis#purduepharma
- Consulting firm McKinsey to pay $78M in U.S. opioid settlement with health insurers, company benefit plans Fox Business
- McKinsey to pay $78M US opioid settlement with health insurers, company benefit plans The Hill
- McKinsey to pay $78 million in US opioid settlement over its work for drug firms like Purdue Pharma NBC News
- McKinsey to Pay $78 Million to Settle Opioid Claims by Insurers Bloomberg
- Consulting giant McKinsey agrees to $78 million settlement in opioid case Hindustan Times
Want the full story? Read the original reporting
Read on Fox Business